Microbial induction of immunity, inflammation, and cancer - PubMed (original) (raw)

Microbial induction of immunity, inflammation, and cancer

Julia B Greer et al. Front Physiol. 2011.

Abstract

The human microbiota presents a highly active metabolic that influences the state of health of our gastrointestinal tracts as well as our susceptibility to disease. Although much of our initial microbiota is adopted from our mothers, its final composition and diversity is determined by environmental factors. Westernization has significantly altered our microbial function. Extensive experimental and clinical evidence indicates that the westernized diet, rich in animal products and low in complex carbohydrates, plus the overuse of antibiotics and underuse of breastfeeding, leads to a heightened inflammatory potential of the microbiota. Chronic inflammation leads to the expression of certain diseases in genetically predisposed individuals. Antibiotics and a "clean" environment, termed the "hygiene hypothesis," has been linked to the rise in allergy and inflammatory bowel disease, due to impaired beneficial bacterial exposure and education of the gut immune system, which comprises the largest immune organ within the body. The elevated risk of colon cancer is associated with the suppression of microbial fermentation and butyrate production, as butyrate provides fuel for the mucosa and is anti-inflammatory and anti-proliferative. This article will summarize the work to date highlighting the complicated and dynamic relationship between the gut microbiota and immunity, inflammation and carcinogenesis.

Keywords: allergy; colon cancer; diet; inflammatory bowel disease; microbiota.

PubMed Disclaimer

Figures

Figure 1

Figure 1

16S rRNA gene surveys reveal a clear separation of two children populations investigated. (A,B) Pie charts of median values of bacterial genera present in fecal samples of Burkina Faso (BF) and European Union (EU) children (>3%) found by RDP classifier v. 2.1. Rings represent corresponding phylum (Bacteroidetes in green and Firmicutes in red) for each of the most frequently represented genera. (C) Dendrogram obtained with complete linkage hierarchical clustering of the samples from BF and EU populations based on their genera. The subcluster located in the middle of the tree contains samples taken from the three youngest (1–2 years old) children of the BF group (16BF, 3BF, and 4BF) and two 1-year-old children of the EU group (2EU and 3EU). (D) Relative abundances (percentage of sequences) of the four most abundant bacterial phyla in each individual among the BF and EU children. Blue area in middle shows abundance of Actinobacteria, mainly represented by Bifidobacterium genus, in the five youngest EU and BF children. (E) Relative abundance (percentage of sequences) of Gram-negative and Gram-positive bacteria in each individual. Different distributions of Gram-negative and Gram-positive in the BF and EU populations reflect differences in the two most represented phyla, Bacteroidetes and Firmicutes. Adapted from De Filippo et al. (2010).

Figure A1

Figure A1

The relationship between macronutrients and fiber with enteric bacteria and the intestinal mucosa.

Similar articles

Cited by

References

    1. Abraham C., Cho J. H. (2009). Inflammatory bowel disease. N. Engl. J. Med. 361, 2066–2078 - PMC - PubMed
    1. Abt M. C., Artis D. (2009). The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis. Curr. Opin. Gastroenterol. 25, 496–502 - PMC - PubMed
    1. Adlerberth I., Jalil F., Carlsson B., Mellander L., Hanson L. A., Larsson P., Khalil K., Wold A. E. (1998). High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Epidemiol. Infect. 121, 587–598 - PMC - PubMed
    1. Ananthakrishnan A. N., Issa M., Binion D. G. (2009). Clostridium difficile and inflammatory bowel disease. Gastroenterol. Clin. North Am. 38, 711–728 - PubMed
    1. Angulo S., Llopis M., Antolin M., Gironella M., Sans M., Malagelada J. R., Pique J. M., Guarner F., Panes J. (2006). Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G1155–G1162. - PubMed

LinkOut - more resources